Barrett's esophagus

[1]  S. Spechler,et al.  Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.

[2]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[3]  D. Kerr,et al.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.

[4]  R. Sampliner,et al.  Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.

[5]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[6]  M. Loda,et al.  Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. , 1998, Cancer research.

[7]  M. Emond,et al.  Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. , 1996, Oncogene.

[8]  N. Shepherd,et al.  c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. , 1995, Journal of clinical pathology.

[9]  R. Goyal,et al.  Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.

[10]  C. Harris,et al.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Fulcheri,et al.  Mucin histochemical analysis in the interpretation of Barrett's esophagus. Results of a multicenter study. The Operative Group for the Study of Esophageal Precancer. , 1992, American journal of clinical pathology.

[12]  K. Takubo,et al.  Double muscularis mucosae in Barrett's esophagus. , 1991, Human pathology.

[13]  H. J. Mcclung,et al.  Intestinal metaplasia is age related in Barrett's esophagus. , 1990, Archives of pathology & laboratory medicine.

[14]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[15]  B. Reid,et al.  Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[16]  C. Rubio,et al.  Musculo-fibrous anomaly in Barrett's mucosa with dysplasia. , 1988, The American journal of surgical pathology.

[17]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[18]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[19]  E. Sweeney,et al.  The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus , 1987, Histopathology.

[20]  G. Chejfec,et al.  Atypias, dysplasias, and neoplasias of the esophagus and stomach. , 1985, Seminars in diagnostic pathology.

[21]  R. Lee.  Mucins in Barrett's esophagus: a histochemical study. , 1984, American journal of clinical pathology.

[22]  F. Pindyck,et al.  Zollinger-Ellison syndrome with esophagitis and Barrett mucosa. , 1983, The American journal of gastroenterology.

[23]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[24]  S. Mossberg,et al.  The columnar-lined esophagus (Barrett syndrome)--an acquired condition? , 1966, Gastroenterology.

[25]  P. Allison,et al.  The Oesophagus Lined with Gastric Mucous Membrane , 1953, Thorax.

[26]  K. Sugimachi,et al.  Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. , 2002, Human pathology.

[27]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[28]  B. Overholt,et al.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.

[29]  H. Barr,et al.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.

[30]  A. Chambers,et al.  p53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study. , 1994, Cancer detection and prevention.

[31]  J. Roth,et al.  Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. , 1994, American journal of surgery.

[32]  D. Hopwood,et al.  Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. , 1992, Scandinavian journal of gastroenterology.

[33]  N R BARRETT,et al.  Chronic peptic ulcer of the oesophagus and 'oesophagitis'. , 1950, The British journal of surgery.